Scarica l'app Stockscreener
0.6203
2.71%
-0.0173
Dopo l'orario di chiusura:
.62
-0.0003
-0.05%
Precedente Chiudi:
$0.6376
Aprire:
$0.68
Volume 24 ore:
104.01K
Relative Volume:
0.18
Capitalizzazione di mercato:
$15.44M
Reddito:
$411.00K
Utile/perdita netta:
$-4.85M
Rapporto P/E:
-1.4098
EPS:
-0.44
Flusso di cassa netto:
$-4.88M
1 W Prestazione:
-6.30%
1M Prestazione:
-19.43%
6M Prestazione:
-25.58%
1 anno Prestazione:
-59.19%
Intervallo 1D:
$0.6131
$0.68
Intervallo di 1 settimana:
$0.6131
$0.7949
Portata 52W:
$0.46
$1.8955
Lexaria Bioscience Corp Stock (LEXX) Company Profile
Nome
Lexaria Bioscience Corp
Settore
Industria
Telefono
250-765-6424
Indirizzo
100 - 740 MCCURDY ROAD, KELOWNA
Compare LEXX vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LEXX
Lexaria Bioscience Corp
|
0.6203 | 15.87M | 411.00K | -4.85M | -4.88M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Lexaria Bioscience Corp Borsa (LEXX) Ultime notizie
Analysts Set Expectations for LEXX FY2028 Earnings - Defense World
Quarterly Earnings: Is Lexaria Bioscience Corp a strong candidate for buy and holdMarket Growth Summary & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Lexaria Bioscience Stock Price, News, Quote & History - Investing News Network
Bear Alert: Can Lexaria Bioscience Corp expand into new markets2025 Market WrapUp & Weekly Top Gainers Trade List - baoquankhu1.vn
Aug Swings: What is Lexaria Bioscience Corp Equity Warrants revenue forecastJuly 2025 Spike Watch & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Hedge Fund Moves: Does Lexaria Bioscience Corp have declining or rising EPSWeekly Stock Recap & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Lexaria Bioscience Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Lexaria’s Oral Liraglutide Shows Comparable Performance and Fewer Side Effects in Human Study - TipRanks
Lexaria Bioscience (LEXX) Demonstrates Promising Results in Late - GuruFocus
Lexaria Announces Positive Final Results from Human Pilot Study #5 - Investing News Network
Lexaria Announces Positive Final Results From Human Pilot Study #5 - Corsicana Daily Sun
Experimental liraglutide pill shows similar results, 67% less nausea - Stock Titan
Signal Recap: Does Lexaria Bioscience Corp offer margin of safetyPortfolio Return Summary & AI Powered Market Entry Ideas - baoquankhu1.vn
Aug Outlook: What is Lexaria Bioscience Corp. Equity Warrant s revenue forecastBreakout Watch & Fast Gaining Stock Reports - baoquankhu1.vn
Aug Levels: Can Lexaria Bioscience Corp sustain its profitabilityJuly 2025 Reactions & Accurate Entry/Exit Alerts - baoquankhu1.vn
Jobs Data: Will Lexaria Bioscience Corp Equity Warrant stock go up in YEAR2025 Growth vs Value & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Portfolio Recap: Is Lexaria Bioscience Corp Equity Warrant currently under institutional pressureJuly 2025 Volume & Weekly Return Optimization Plans - baoquankhu1.vn
Aug Sectors: Is Lexaria Bioscience Corp exposed to political riskWeekly Trading Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
Market Rankings: Is Lexaria Bioscience Corp benefiting from interest rate changesWeekly Earnings Recap & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Is Lexaria Bioscience Corp.’s ROE strong enoughJuly 2025 Catalysts & Short-Term High Return Ideas - mfd.ru
Lexaria Bioscience shareholders approve board elections and auditor at annual meeting By Investing.com - Investing.com South Africa
Lexaria Bioscience shareholders approve board elections and auditor at annual meeting - Investing.com Nigeria
Is Lexaria Bioscience Corp. Equity Warrant currently under institutional pressureTake Profit & Safe Capital Growth Tips - mfd.ru
Lexaria Bioscience plummets on $3.5M equity offering - MSN
Is Lexaria Bioscience Corp. exposed to political riskTrade Analysis Report & Accurate Buy Signal Notifications - mfd.ru
Lexaria Awarded Six Additional Patents - New Castle News
Investor Mood: Is Fiverr International Ltd. forming a breakout patternQuarterly Portfolio Report & Weekly High Potential Stock Alerts - baoquankhu1.vn
Lexaria Adds Six Global Patents, Reaches 60 Granted as It Rallies Shareholders Ahead of 2026 Meeting - The Globe and Mail
Lexaria reaches milestone with 60 patents granted worldwide By Investing.com - Investing.com Nigeria
Lexaria Bioscience Expands Global Patent Portfolio to 60 Granted Patents - citybuzz -
LEXX Strengthens Patent Portfolio with New International Approva - GuruFocus
Lexaria reaches milestone with 60 patents granted worldwide - Investing.com
International Business Times - FinancialContent
Aug Big Picture: Can Lexaria Bioscience Corp. ride the EV waveTrade Signal Summary & Fast Gaining Stock Reports - baoquankhu1.vn
THE FOCUS DOCTRINE: 5 Assets Securing the 2026 Biological Choke Point - Investing News Network
Risk Check: Will Lexaria Bioscience Corp outperform small cap indexesWeekly Stock Report & Reliable Price Action Trade Plans - baoquankhu1.vn
What catalysts could drive Lexaria Bioscience Corp. Equity Warrant stock higherEarnings Summary Report & Fast Moving Market Watchlists - bollywoodhelpline.com
Should I trade or invest in Lexaria Bioscience Corp. Equity WarrantStock Surge & Risk Controlled Swing Trade Alerts - bollywoodhelpline.com
Aug Big Picture: What hedge funds are buying Lexaria Bioscience CorpEarnings Growth Report & Stock Portfolio Risk Management - baoquankhu1.vn
Market Leaders: Can Lexaria Bioscience Corp ride the EV waveWeekly Loss Report & Consistent Growth Stock Picks - baoquankhu1.vn
Published on: 2026-01-15 23:22:36 - baoquankhu1.vn
Levels Update: What are Lexaria Bioscience Corp. Equity Warrant’s earnings expectationsMarket Movers & Verified Momentum Stock Alerts - baoquankhu1.vn
Lexaria Bioscience Corp. SEC 10-Q Report - TradingView
Institution Moves: Is Lexaria Bioscience Corp stock a bargain at current levels2025 Valuation Update & Real-Time Buy Signal Notifications - Bộ Nội Vụ
Lexaria’s DehydraTECH shows reduced side effects in GLP-1 drugs By Investing.com - Investing.com Nigeria
Lexaria Deepens GLP-1 Focus With DehydraTECH Advances, Patents and Fresh Capital - TipRanks
Lexaria’s DehydraTECH shows reduced side effects in GLP-1 drugs - Investing.com
Lexaria Bioscience Corp Azioni (LEXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):